Management of febrile neutropenia: ESMO Clinical Recommendations

被引：22
作者：
Marti, F. Marti [1 ]
Cullen, M. H. [1 ]
Roila, F. [2 ]
机构：
[1] Univ Hosp Birmingham, Dept Med Oncol, NHS Fdn Trust, Birmingham, W Midlands, England
[2] S Maria Hosp, Dept Med Oncol, Terni, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
MULTINATIONAL-ASSOCIATION; ANTIBIOTIC-TREATMENT; SUPPORTIVE-CARE; CANCER-PATIENTS; RISK INDEX; METAANALYSIS; OUTPATIENT;
D O I：
10.1093/annonc/mdp163
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：166 / 169
页数：4
相关论文
共 10 条
  • [1] [Anonymous], COCHRANE DATABASE SY
  • [2] Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia
    Elting, Linda S.
    Lu, Charles
    Escalante, Carmelita P.
    Giordano, Sharon H.
    Trent, Jonathan C.
    Cooksley, Catherine
    Avritscher, Elenir B. C.
    Shih, Ya-Chen Tina
    Ensor, Joe
    Bekele, B. Nebiyou
    Gralla, Richard J.
    Talcott, James A.
    Rolston, Kenneth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 606 - 611
  • [3] Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis
    Furno, P
    Bucaneve, G
    Del Favero, A
    [J]. LANCET INFECTIOUS DISEASES, 2002, 2 (04) : 231 - 242
  • [4] Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy:: Causes and consequences
    Hamalainen, Sari
    Kuittinen, Taru
    Marinlauri, Irma
    Nousiainen, Tapio
    Koivula, Irma
    Jantunen, Esa
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (03) : 495 - 501
  • [5] Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice
    Innes, Helen
    Lim, Sheow Lei
    Hall, Allison
    Chan, Su Yin
    Bhalla, Neeraj
    Marshall, Ernest
    [J]. SUPPORTIVE CARE IN CANCER, 2008, 16 (05) : 485 - 491
  • [6] Innes H, 2007, CURR OPIN ONCOL, V19, P294
  • [7] Bacterial infections in low-risk, febrile neutropenic patients - Over a decade of experience at a comprehensive cancer center
    Kamana, M
    Escalante, C
    Mullen, CA
    Frisbee-Hume, S
    Rolston, KVI
    [J]. CANCER, 2005, 104 (02) : 422 - 426
  • [8] Pathogen 'shift' in febrile neutropenia
    Kibbler, CC
    Prentice, HG
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 1999, 12 (04) : 351 - 354
  • [9] The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
    Klastersky, J
    Paesmans, M
    Rubenstein, EB
    Boyer, M
    Elting, L
    Feld, R
    Gallagher, J
    Herrstedt, J
    Rapoport, B
    Rolston, K
    Talcott, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 3038 - 3051
  • [10] Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials
    Vidal, L
    Paul, M
    Ben dor, I
    Soares-Weiser, K
    Leibovici, L
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) : 29 - 37
1